ID: ALA5218552

Max Phase: Preclinical

Molecular Formula: C23H25ClF2N6O4

Molecular Weight: 522.94

Associated Items:

Representations

Canonical SMILES:  COC(=O)[C@@H]1COCCN1CCOc1ccccc1Cc1cn(C(F)F)nc1-c1cc(Cl)nc(N)n1

Standard InChI:  InChI=1S/C23H25ClF2N6O4/c1-34-21(33)17-13-35-8-6-31(17)7-9-36-18-5-3-2-4-14(18)10-15-12-32(22(25)26)30-20(15)16-11-19(24)29-23(27)28-16/h2-5,11-12,17,22H,6-10,13H2,1H3,(H2,27,28,29)/t17-/m0/s1

Standard InChI Key:  XHTFJTUBYAPEAW-KRWDZBQOSA-N

Associated Targets(Human)

Adenylate cyclase type 10 96 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Adenylate cyclase type 10 11 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 522.94Molecular Weight (Monoisotopic): 522.1594AlogP: 2.81#Rotatable Bonds: 9
Polar Surface Area: 117.62Molecular Species: NEUTRALHBA: 10HBD: 1
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 4.43CX LogP: 4.07CX LogD: 4.07
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.33Np Likeness Score: -1.06

References

1. Miller M, Rossetti T, Ferreira J, Ghanem L, Balbach M, Kaur N, Levin LR, Buck J, Kehr M, Coquille S, van den Heuvel J, Steegborn C, Fushimi M, Finkin-Groner E, Myers RW, Kargman S, Liverton NJ, Huggins DJ, Meinke PT..  (2022)  Design, Synthesis, and Pharmacological Evaluation of Second-Generation Soluble Adenylyl Cyclase (sAC, ADCY10) Inhibitors with Slow Dissociation Rates.,  65  (22.0): [PMID:36346696] [10.1021/acs.jmedchem.2c01133]

Source